HeartSciences Inc (HSCS) Price Prediction & ForecastHSCSHeartSciences Inc

Alphio's HSCS stock price prediction model matches the current HeartSciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.81 (-0.55%). The 1-week path is $2.76 (-2.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Heart Test Laboratories Inc (HSCS) is currently not a strong buy due to its recent performance and financial instability. The stock is priced at $2.83, which is significantly below its 52-week high of $5.25, indicating a 46.5% drop from its peak. Additionally, the RSI is at 38.7, suggesting that the stock is nearing oversold territory but still lacks strong upward momentum. The company reported a gross margin of 59.06% in Q2 2026, which is positive, but it also posted a net income loss of $2.35 million in the same quarter. The primary risk is the ongoing financial losses, with a projected EPS of -0.86 for Q4 2026, indicating continued negative earnings performance. Therefore, while there are some positive indicators, the overall financial health and recent stock performance suggest holding rather than buying at this time.

HeartSciences Inc (HSCS) last closed at $2.8299999, gaining +5.99%. These facts feed the 1-day and 1-week HSCS price prediction above.